SXTP
60 Degrees Pharma Inc
NASDAQ · Pharmaceuticals
$4.16
+0.31 (+8.05%)
Open$3.78
Previous Close$3.85
Day High$4.16
Day Low$3.56
52W High$3.02
52W Low$1.78
Volume—
Avg Volume677.1K
Market Cap4.40M
P/E Ratio22.40
EPS$0.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
-36.1% upside
Current
$4.16
$4.16
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 976.3K | 862.6K | 990.0K |
| Net Income | 166.4K | 198.9K | 215.4K |
| Profit Margin | 17.1% | 23.1% | 21.8% |
| EBITDA | 375.1K | 334.7K | 417.4K |
| Free Cash Flow | 225.2K | 224.8K | 208.8K |
| Rev Growth | +8.4% | -6.7% | +4.7% |
| Debt/Equity | 0.57 | 0.52 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |